This is the protocol for a review and there is no abstract. The objectives are as follows:
To establish the efficacy and safety of botulinum toxin aimed at improving UOS dysfunction in people with non progressive and progressive neurological disease.
To provide the best evidence to inform clinical practice.
To assist with future research planning.
If you can't find a tool you're looking for, please click the link at the top of the page to "Go to old article view". Alternatively, view our Knowledge Base articles for additional help. Your feedback is important to us, so please let us know if you have comments or ideas for improvement.